Author:
Volberg Christian,Schmidt-Semisch Henning,Maul Julian,Nadig Jens,Gschnell Martin
Abstract
Abstract
Background and objectives
Pain management is a necessary component of palliative care as most patients suffer from pain during the final phase of life. Due to the complex causation of pain in the last phase of life, it is important to utilize methods other than pharmacotherapeutic options in order to achieve adequate pain control. As little is known about treatment of pain in German hospices, a nationwide survey was conducted.
Materials and methods
All German hospices (259) were contacted by post in June 2020 and asked to participate in an anonymous cross-sectional survey.
Results
A total of 148 (57%) German hospices took part in the survey. A broad variety of medication is used in the hospice setting. Metamizole is the most commonly used non-opiod analgesic , hydromorphone the most commonly used opioid, and pregabalin is the most commonly prescribed co-analgesic drug. The pain medication is usually prescribed as an oral slow-release substance. Standardized treatment schemes are rare among the responding hospices. Most of the respondents also use complementary treatment options, such as aroma (oil) therapy or music therapy, in the treatment of pain. Palliative sedation is used by nearly all responding hospices if all other treatment options fail.
Conclusion
This survey provides an overview of the treatment options for pain management in German hospices. A broad variety of pain medication is used. Compared to international literature, it is debatable whether such a large variety of different types of pain medication is necessary, or whether a reduction in the type of medication available and the use of standardized treatment schemes could benefit everyone involved.
Funder
Philipps-Universität Marburg
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Meier EA, Gallegos JV, Thomas LPM, Depp CA, Irwin SA, Jeste DV. Defining a good death (successful dying): Literature Review and a call for research and public dialogue. The Am J Geriatr Psychiatry. 2016;24(4):261–71.
2. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF). Palliativmedizin für Patienten mit einer nicht-heilbaren Krebserkrankung, Langversion 2.2, 2020, AWMF-Registernummer: 128/001OL. 2020;551.
3. Bausewein C, Roller S, Voltz R, Augustyn B, Schulte O, editors. Leitfaden Palliative Care: Palliativmedizin und Hospizbegleitung. 7. Auflage. München: Elsevier; 2021. 657 S. (Leitfaden).
4. Engel GL. The need for a new medical model: a challenge for biomedicine. Sci 8 April. 1977;196(4286):129–36.
5. Engel GL. The clinical application of the biopsychosocial model. Am J Psychiatry Mai. 1980;137(5):535–44.